Deanna Horner, EVP of Enterprise DIRECT Strategy at EVERSANA, breaks down what's fueling pharma's embrace of direct-to-patient models.
Deanna Horner
Advertisement
Deanna Horner is executive vice president, Enterprise DIRECT Strategy, at EVERSANA.
Articles by Deanna Horner
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Seven Companies Selected for FDA Pilot to Strengthen US Drug Supply Chain
2
Q&A: What It Will Take to Scale CGT Supply Chains
3
Gerren McHam on the Future of US Pharma Reshoring
4
The Hidden Architecture of Drug Shortages: Why Inventory Economics Determine Patient Access
5